Aurinia Pharmaceuticals I...

NASDAQ: AUPH · Real-Time Price · USD
12.27
0.18 (1.49%)
At close: Aug 15, 2025, 3:59 PM
12.44
1.43%
After-hours: Aug 15, 2025, 07:44 PM EDT

Aurinia Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
70.01M 62.47M 59.87M 67.77M 57.19M 50.3M 45.09M 54.52M 41.49M 34.41M 28.43M 55.78M 28.19M 21.63M 23.4M 14.67M 6.62M 914K
Cost of Revenue
7.12M 8.57M 5.55M 6.04M 8.91M 7.75M 5.39M 6.77M 1.56M 421K 1.36M 2.45M 1.6M 256K 481K 254K 308K 48K
Gross Profit
62.89M 53.89M 54.31M 61.74M 48.28M 42.55M 39.7M 47.75M 39.93M 33.99M 27.07M 53.33M 26.59M 21.37M 22.92M 14.41M 6.31M 866K
Operating Income
20.08M 21.85M -1.67M 11.75M -731K -10.7M -20.6M -16.26M -16.17M -29.58M -28.1M -9.5M -35.99M -37.88M -32.7M -50.35M -47.13M -50.54M
Interest Income
3.19M 3.57M 3.99M 4.27M 4.19M 4.53M 4.57M 4.51M 4.1M 3.81M 2.91M 1.46M 483K 262K 109K 106K 142K 172K
Pretax Income
22.16M 24.35M 1.17M 14.81M 1.48M -10.01M -26.42M -13.15M -12.13M -25.77M -25.19M -8.04M -35.51M -37.62M -32.6M -50.25M -46.99M -50.37M
Net Income
21.51M 23.34M 1.43M 14.35M 722K -10.75M -26.88M -13.45M -11.49M -26.21M -26.05M -8.99M -35.52M -37.63M -33.32M -50.26M -47.01M -50.38M
Selling & General & Admin
26.02M 20.34M 37.03M 39.64M 44.93M 47.7M 50.07M 47.76M 47.08M 50.12M 47.47M 52.17M 51.53M 45.2M 44.24M 44.13M 43.79M 39.28M
Research & Development
7.43M 5.74M 8.11M 3.05M 4.08M 5.55M 10.23M 13.61M 12.65M 13.16M 9.87M 10.97M 11.53M 12.62M 11.15M 20.07M 10.09M 9.83M
Other Expenses
9.36M 5.96M 2.62M 7.3M n/a n/a n/a 2.65M n/a 290K -2.17M -311K -476K 1.43M 237K 572K -431K -1.77M
Operating Expenses
42.81M 32.04M 55.98M 49.99M 49.01M 53.25M 60.3M 64.01M 56.1M 63.57M 55.17M 62.83M 62.58M 59.25M 55.63M 64.77M 53.45M 49.64M
Interest Expense
1.12M 1.07M 1.15M 1.21M 1.2M 1.28M 1.31M 1.4M 65K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
848K n/a 14.09M n/a 2.65M 2.84M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
49.92M 40.62M 61.54M 56.02M 57.92M 61M 65.69M 70.78M 57.66M 63.99M 56.53M 65.28M 64.18M 59.51M 56.11M 65.02M 53.75M 49.69M
Income Tax Expense
643K 1M -256K 457K 756K 739K 459K 298K -642K 436K 855K 954K 9K 10K 726K 8K 18K 8K
Shares Outstanding (Basic)
138.92M 138.92M 142.18M 143.05M 143.33M 144.01M 143.83M 142.85M 142.78M 142.64M 142.27M 141.86M 141.73M 139.37M 130.69M 128.44M 128.22M 127.4M
Shares Outstanding (Diluted)
143.2M 143.2M 147.68M 145.65M 144.11M 144.01M 143.83M 142.85M 142.78M 142.64M 142.27M 141.86M 141.73M 141.68M 132.05M 128.44M 128.22M 127.4M
EPS (Basic)
0.15 0.17 0.01 0.10 0.01 -0.07 -0.19 -0.09 -0.08 -0.18 -0.18 -0.06 -0.25 -0.27 -0.25 -0.39 -0.37 -0.4
EPS (Diluted)
0.15 0.16 0.01 0.10 0.01 -0.07 -0.19 -0.09 -0.08 -0.18 -0.18 -0.06 -0.25 -0.27 -0.25 -0.39 -0.37 -0.4
EBITDA
28.14M 30.27M 7.18M 20.91M 4.4M -3.88M -20.16M -6.29M -11.35M -25.05M -27.88M -7.23M -34.52M -36.78M -31.97M -49.67M -46.43M -49.85M
EBIT
23.27M 25.42M 2.32M 16.02M 2.68M -8.73M -25.11M -11.75M -12.07M -25.77M -28.1M -8.04M -35.51M -37.88M -32.7M -50.35M -47.13M -50.54M
Depreciation & Amortization
4.86M 4.86M 4.86M 4.89M 4.84M 4.85M 4.95M 5.46M 719K 717K 219K 809K 991K 838K 688K 717K 736K 688K